Applied Molecular Transport Inc.
NASDAQ:AMTI
Intrinsic Value
Applied Molecular Transport, Inc. is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment o... [ Read More ]
The intrinsic value of one AMTI stock under the Base Case scenario is 1.453 USD. Compared to the current market price of 0.263 USD, Applied Molecular Transport Inc. is Undervalued by 82%.
Valuation Backtest
Applied Molecular Transport Inc.
Run backtest to discover the historical profit from buying and selling AMTI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Applied Molecular Transport Inc.'s business.
What risks and challenges
does Applied Molecular Transport Inc. face in the near future?
Summarize the latest earnings report
of Applied Molecular Transport Inc..
Provide P/E
for Applied Molecular Transport Inc. and its competitors.
Balance Sheet Decomposition
Applied Molecular Transport Inc.
Current Assets | 18.8m |
Cash & Short-Term Investments | 18.1m |
Other Current Assets | 700k |
Non-Current Assets | 1.2m |
PP&E | 1.2m |
Current Liabilities | 3.8m |
Accounts Payable | 200k |
Accrued Liabilities | 3.6m |
Earnings Waterfall
Applied Molecular Transport Inc.
Revenue
|
0
USD
|
Operating Expenses
|
-59.7m
USD
|
Operating Income
|
-59.7m
USD
|
Other Expenses
|
-15.1m
USD
|
Net Income
|
-74.8m
USD
|
Free Cash Flow Analysis
Applied Molecular Transport Inc.
What is Free Cash Flow?
AMTI Profitability Score
Profitability Due Diligence
Applied Molecular Transport Inc.'s profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
Applied Molecular Transport Inc.'s profitability score is 27/100. The higher the profitability score, the more profitable the company is.
AMTI Solvency Score
Solvency Due Diligence
Applied Molecular Transport Inc.'s solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
Applied Molecular Transport Inc.'s solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AMTI Price Targets Summary
Applied Molecular Transport Inc.
According to Wall Street analysts, the average 1-year price target for AMTI is 1 USD .
Ownership
AMTI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
AMTI Price
Applied Molecular Transport Inc.
Average Annual Return | 9.26% |
Standard Deviation of Annual Returns | 91.83% |
Max Drawdown | -100% |
Market Capitalization | 10.8m USD |
Shares Outstanding | 41 849 000 |
Percentage of Shares Shorted | 0.81% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Applied Molecular Transport, Inc. is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment of autoimmune, inflammatory, and metabolic diseases. The company is headquartered in South San Francisco, California and currently employs 125 full-time employees. The company went IPO on 2020-06-05. The firm is leveraging its technology platform to design and develop a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The firm is building a portfolio of oral product candidates based on its technology platform, including AMT-101, an oral gastrointestinal (GI)-selective oral fusion of interleukin 10 (IL-10) that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). The Company’s other product candidate, AMT-126, is a GI-selective oral fusion of interleukin 22 (IL-22). Its technology platform enables it to design and develop various oral biologic therapeutic modalities, such as peptides, proteins, full-length antibodies, antibody fragments, and ribonucleic acid (RNA) therapeutics with development-stage drugs.
Contact
IPO
Employees
Officers
The intrinsic value of one AMTI stock under the Base Case scenario is 1.453 USD.
Compared to the current market price of 0.263 USD, Applied Molecular Transport Inc. is Undervalued by 82%.